Eli Lilly invites you to an interactive webinar on identifying patients with HR+ HER2- breast cancer who are at high risk of recurrence or progression. In this session, renowned medical oncologists Dr. Shyam Aggarwal, Dr. Manasi Shah, and Dr. Chandrakanth MV will review 7-year data from the landmark monarchE trial, discuss early breast cancer cases and their multidisciplinary team (MDT) implications, and explore the role of abemaciclib in endocrine-sensitive metastatic breast cancer.
The session will also feature an interactive Q&A with the experts, providing an opportunity to discuss real-world strategies and practical clinical considerations for improving outcomes in patients with breast cancer. Join the experts on July 24 , 2025 , at 7:00 PM IST to stay up to date with the latest developments in breast cancer care. We hope you can join us for this insightful discussion. Agenda :…
